Loading...
XPAR
BIM
Market cap10bUSD
Aug 28, Last price  
75.25EUR
Name

Biomerieux SA

Chart & performance

D1W1MN
XPAR:BIM chart
P/E
22.34
P/S
2.18
EPS
3.37
Div yield, %
1.20%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
5.47%
Revenues
Net income
CFO
Dividend
Jun 09, 20260.98 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
IPO date
Jun 07, 2004
Employees
12,557
Domiciled in
FR
Incorporated in
FR

Valuation

No data to show